(Q36635593)

15 August 2017

1 reference

title

The hepatitis B virus and the host response (English)

1 reference

15 August 2017

1 reference

1 reference

H. C. Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706740

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1706740

3 November 2022

publication date

1 January 1990

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:016882789090170V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

https://api.elsevier.com/content/article/PII:016882789090170V?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

3 November 2022

published in

Journal of Hepatology

1 reference

15 August 2017

volume

11 Suppl 1

1 reference

15 August 2017

page(s)

S83-9

1 reference

Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection

15 August 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

The HLA system: its relevance to the pathogenesis of liver disease

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

3 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

3 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Demonstration of albumin receptors onisolated human hepatocytes by light and scanning electron microscopy

3 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides

3 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

3 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Hepatitis B virus contains pre-S gene-encoded domains

3 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.

3 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

3 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

3 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Tolerance and suppression in virus diseases

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

3 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

3 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

3 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

3 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Defective response to interferons in cells transfected with the hepatitis B virus genome

3 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. An analysis of 110 liver biopsies.

3 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

3 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

3 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Homology between HBV-DNA and a sequence regulating the interferon-induced antiviral system: possible mechanism of persistent infection

3 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

3 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Histological improvement after anti-viral treatment for chronic hepatitis B virus infection

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Reactivation of chronic type B hepatitis presenting as acute viral hepatitis

3 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

3 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results

3 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

3 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

3 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

Antiviral therapy in hepatitis B infection

3 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90170-V

3 November 2022

Identifiers

1 reference

15 August 2017

1 reference